A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

ClinicalTrials.gov ID: NCT07143968

Public ClinicalTrials.gov record NCT07143968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 6, 2026, 9:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Resmetirom for the Treatment of Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) in People Living With Human Immunodeficiency Virus (HIV)

Study identification

NCT ID: NCT07143968
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Naga P. Chalasani; Other
Enrollment: 120 participants

Conditions and interventions

Conditions

Interventions

Placebo Control Drug
Resmetirom Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 22, 2026
Primary completion: Sep 30, 2027
Completion: Oct 31, 2027
Last update posted: May 5, 2026

2026 – 2027

United States locations

U.S. sites: 10
U.S. states: 9
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of Alabama Birmingham	Birmingham	Alabama	35294	Not yet recruiting
UC San Diego Altman Clinical and Translational Research Institute	La Jolla	California	92037	Not yet recruiting
University of California, San Francisco	San Francisco	California	94143	Not yet recruiting
Atlantic Clinical Research Institute	West Palm Beach	Florida	33409	Not yet recruiting
Indiana University	Indianapolis	Indiana	46202	Recruiting
Johns Hopkins University	Baltimore	Maryland	21205	Not yet recruiting
Mt Sinai Health System	New York	New York	10029	Not yet recruiting
Duke University Medical Center	Durham	North Carolina	27710	Not yet recruiting
UT Health Houston	Houston	Texas	77030	Not yet recruiting
Virginia Commonwealth University	Richmond	Virginia	23298	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07143968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 5, 2026 · Synced May 6, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07143968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →